The chemicals listed above have been selected based on their capacity to indirectly activate PRRT1 by modulating associated neural pathways. For example, Anisomycin and Forskolin activate the JNK pathway and adenylyl cyclase respectively, both of which play a significant role in synaptic functions. Elevated cAMP levels and JNK pathway activation can upregulate PRRT1. Picrotoxin and Bicuculline serve as GABA_A receptor antagonists and increase neural excitability, which indirectly activates PRRT1 due to its role in synapse formation and function.
The second set of chemicals including Nifedipine, CNQX, and ZD7288 target specific ion channels and neurotransmitter receptors, thereby affecting calcium and glutamatergic signaling. These pathways are fundamental to neuronal activity and synapse formation, processes that PRRT1 is involved in. Nifedipine, a calcium channel blocker, regulates calcium signaling which can activate PRRT1. CNQX and NBQX, as AMPA receptor antagonists, modify glutamatergic signaling and can lead to PRRT1 activation. The influence of these chemicals on ion channels and neurotransmitter receptors is aligned with PRRT1 activation due to its synaptic role.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates JNK pathway, which can lead to enhanced synaptic functions, thereby activating PRRT1. | ||||||
Picrotoxin | 124-87-8 | sc-202765 sc-202765A sc-202765B | 1 g 5 g 25 g | $67.00 $286.00 $1326.00 | 11 | |
GABA_A receptor antagonist, increases neural excitability and indirectly activates PRRT1. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylyl cyclase and increases cAMP levels, which can upregulate PRRT1. | ||||||
(+)-Bicuculline | 485-49-4 | sc-202498 sc-202498A | 50 mg 250 mg | $82.00 $281.00 | ||
Another GABA_A antagonist that can increase neural excitability, thereby activating PRRT1. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
L-type calcium channel blocker, affecting calcium signaling, which can activate PRRT1. | ||||||
6-Cyano-7-nitroquinoxaline-2,3-dione | 115066-14-3 | sc-505104 | 10 mg | $208.00 | 2 | |
AMPA receptor antagonist, modifies glutamatergic signaling and can activate PRRT1. | ||||||
6-Nitro-7-sulfamoylbenzo[f]quinoxaline-2,3-Dione | 118876-58-7 | sc-478080 | 5 mg | $70.00 | 1 | |
Another AMPA receptor antagonist, modifies glutamatergic signaling and can activate PRRT1. | ||||||
D(−)-2-Amino-5-phosphonovaleric acid (D-AP5) | 79055-68-8 | sc-200434 | 5 mg | $97.00 | 2 | |
NMDA receptor antagonist, alters glutamatergic transmission and can activate PRRT1. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic receptor agonist, affecting cAMP levels and PKA signaling which can activate PRRT1. | ||||||